Surgical skills test is reliable


Microsurgical lab testing is a reliable method for assessing ophthalmology resident's surgical skills.

Microsurgical lab testing is a reliable method for assessing ophthalmology resident's surgical skills, according to a report published online ahead of print by the British Journal of Ophthalmology.

Jennifer Taylor from the Children's Hospital of Philadelphia and colleagues from the University of California and the University of Pennsylvania, USA conducted a study to determine the inter-rate reliability and construct validity of the Eye Surgical Skills Assessment Test (ESSAT).

ESSAT is a laboratory-based surgical skills 'obstacle course' which was developed in response to the need for improved tools for the assessment of surgical skills during residency.

Twenty-seven content experts (programme directors and faculty members involved in resident surgical training) watched videos of junior and senior residents completing the three ESSAT stations (skin suturing, muscle recession and phacoemulsification: wound construction & suturing technique) and filled out assessment forms, task specific checklists and a global rating scale of performance.

ESSAT demonstrated good inter-rate reliability for determining whether residents "passed" each section. In addition, at each station the senior resident was consistently rated above the pass threshold whereas the junior residents were more often rated below.

It is the conclusion of the authors that ESSAT is a useful tool that should be integrated into all residency programmes.

Recent Videos
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
Paulo Antonio Silva, Associate Professor of Ophthalmology at Harvard Medical School
Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response
Durga Borkar, MD, MMCi, discusses FAS inhibition with ONL-1204
Theodore Leng, MD, MS, speaks about 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema:The FARETINA-DME Study
Rishi P. Singh, MD, discussed his presentation on the results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
Carl C. Awh, MD, FASRS, speaks with Hattie Hayes of Ophthalmology Times Europe
Carl J. Danzig, MD
Martin Zinkernagel, MD, PhD, speaks about the ASRS sustainability expert panel
Srinivas Sai Kondapalli, MD, discusses outer retinal tubulations in lesion growth for subfoveal and non-subfoveal GA
© 2024 MJH Life Sciences

All rights reserved.